Harrow Health (HROW) Stock Insights

HROW price $29.39 +0.32 +1.10%

Ticker
HROW
Price
$29.39
Change
+0.32 +1.10%
Market cap ?
$1.10B
P/E ?
-28.65
Forward P/E ?
13.48
Dividend yield ?
0.00%
Beta ?
0.24
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stocklytics score
58
Value
42
Quality
39
Growth
93

Stocklytics score rationale: value 42, quality 39, growth 93.

Financials

2016201720182019202020212022202320242025
19942000267740004137200051165000488710007247600088595000130193000199614000272303000

Harrow Health, Inc. operates as a healthcare enterprise with a specialized focus on ophthalmic solutions. The company's portfolio includes ImprimisRx, a business dedicated to ophthalmology outsourcing and pharmaceutical compounding, as well as DEXYCU, a product utilized for managing post-operative inflammation. Beyond its direct offerings, Harrow Health maintains equity investments in several pharmaceutical…

Fair value

HROW fair value $97.14. Price $29.39. Price is 70% below fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 70.59M. Growth 20.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 8.70% (beta 0.8). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 37.49M. Net debt 179.05M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the median P/E of the company's industry. That median uses listed stocks worth at least $10 billion with a positive P/E of 100 or below, and the industry needs at least eight of them. Otherwise the sector median is used when that group also has at least eight, then the market median of those large companies. The multiple used is the lower of that median and 1.25 times the stock's own 10-year median P/E, then kept between 8 and 30. If the stock has no 10-year median, the peer median is kept between 8 and 30. Fair value is the average of the cash-flow value and the earnings value when both exist. Card and credit companies use the earnings value only, because changes in customer receivables distort free cash flow. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Model uncertainty high for this stock

Compare HROW

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-09—0.17—98.47M
2026-08-10-0.46-0.1870.66M70.35M
2026-05-11-0.74-0.4344.20M52.43M
2026-03-020.180.4089.09M90.00M
2025-11-100.030.2271.64M73.70M
2025-08-110.140.0163.74M66.00M
2025-05-08-0.500.0247.83M57.00M
2025-03-270.240.0866.83M61.79M
2024-11-13-0.12-0.0549.26M52.80M
2024-08-07-0.18-0.2548.90M42.51M
2024-05-13-0.38-0.2534.59M36.32M
2024-03-20-0.25-0.0436.35M37.86M
2023-11-13-0.090.0334.30M37.58M
2023-08-09-0.14-0.0433.47M31.04M
2023-05-11-0.22-0.0626.10M25.13M
2023-03-230.07-0.1520.33M21.40M
2022-11-14-0.240.0222.82M23.14M
2022-08-09-0.23-0.0223.32M22.07M
2022-05-05-0.09-0.0422.12M19.48M
2022-03-10-0.27-0.0420.19M19.35M
2021-11-090.050.0318.71M15.44M
2021-08-10-0.09-0.0318.13M15.71M
2021-05-110.01-0.0415.44M13.66M
2021-03-080.040.0414.60M14.45M
2020-11-090.330.1714.40M77.75M
2020-08-10-0.01-0.108.06M80.60M
2020-05-11-0.50-0.2511.82M5.91M
2020-03-130.100.0612.60M7.56M
2019-11-13-0.45-0.4412.76M8.88M
2019-08-14-0.09-0.0813.52M12.01M
2019-05-090.430.1212.29M285.81K
2019-03-120.770.3411.38M5.03M
2018-11-13-0.12—10.74M—
2018-08-060.11—10.38M—
2018-05-15-0.17—8.87M—
2018-03-08-0.13—7.34M—
2017-11-14-0.28—6.48M—
2017-08-100.07—6.86M—
2017-05-10-0.26-0.196.10M4.46M
2017-03-21-0.30-0.285.79M5.40M

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-08-14Shojaei AmirSell11.25K$35.96404.55K
2026-08-14Shojaei AmirBuy11.25K$35.96404.55K
2026-08-14Shojaei AmirSell11.25K$40.00450.00K
2026-06-18Sternberg Perry J.Buy5.25K——
2026-06-18SILVERNAIL LAUREN PBuy5.25K——
2026-06-18Graves Adrienne LBuy5.25K——
2026-05-18Graves Adrienne LBuy1.00K$31.0731.07K
2026-05-18SILVERNAIL LAUREN PBuy1.00K$31.0031.00K
2026-05-15Shojaei AmirBuy10.00K——
2026-05-14BAUM MARK LBuy10.00K$30.20302.00K
2026-05-14BOLL ANDREW R.Buy3.50K$29.90104.65K
2026-03-04Opaleye Management Inc.Sell134.00K$39.675.32M
2026-03-04Opaleye Management Inc.Sell4.26K$39.67169.12K
2026-03-03Opaleye Management Inc.Sell59.00K$39.152.31M
2026-03-03Opaleye Management Inc.Sell1.31K$39.1551.25K
2026-02-27Opaleye Management Inc.Sell5.00K$54.18270.90K
2026-01-30Sullivan Patrick WilliamBuy25.00K——
2026-01-30Sullivan Patrick WilliamBuy15.00K——
2026-01-30Sullivan Patrick WilliamOther30.00K$39.001.17M
2026-01-06Opaleye Management Inc.Sell20.00K$53.351.07M
2025-12-12BOLL ANDREW R.Buy60.00K$3.95237.00K
2025-12-12BOLL ANDREW R.Sell26.66K$47.061.25M
2025-12-12BOLL ANDREW R.Sell60.00K$3.95237.00K
2025-12-12BAUM MARK LBuy180.00K$3.95711.00K
2025-12-12BAUM MARK LSell79.99K$47.063.76M
2025-12-12BAUM MARK LSell180.00K$3.95711.00K
2025-10-06Mullery Francis William JrOther33.00K$48.181.59M
2025-09-01Pollard Randall E.Buy30.00K$39.001.17M
2025-09-01Pollard Randall E.Other0——
2025-07-21BAUM MARK LBuy600.00K$7.874.72M
2025-07-21BAUM MARK LSell313.34K$37.0811.62M
2025-07-01BOLL ANDREW R.Buy405.75K——
2025-07-01BAUM MARK LBuy889.50K——
2025-06-20Sternberg Perry J.Buy7.34K——
2025-06-20SILVERNAIL LAUREN PBuy7.34K——
2025-06-20Graves Adrienne LBuy7.34K——
2025-06-10Opaleye Management Inc.Sell15.00K$30.80462.03K
2025-06-09Opaleye Management Inc.Sell15.20K$30.37461.79K
2025-06-04Opaleye Management Inc.Sell1.80K$30.0253.91K
2025-06-03Opaleye Management Inc.Sell3.00K$30.0490.12K
2025-05-13Opaleye Management Inc.Sell5.00K$26.59132.94K
2025-05-12Opaleye Management Inc.Sell10.00K$25.90258.96K
2025-04-07BOLL ANDREW R.Sell136.75K$23.093.16M
2025-04-07SAHAREK JOHN P.Sell109.47K$23.092.53M
2025-04-07BAUM MARK LSell300.36K$23.096.94M
2025-04-03BOLL ANDREW R.Buy346.50K——
2025-04-03BOLL ANDREW R.Sell346.50K——
2025-04-03SAHAREK JOHN P.Buy277.20K——
2025-04-03SAHAREK JOHN P.Sell277.20K——
2025-04-03BAUM MARK LBuy762.30K——
2025-04-03BAUM MARK LSell762.30K——
2025-03-24Opaleye Management Inc.Sell5.00K$30.01150.06K
2025-03-18Opaleye Management Inc.Sell5.00K$30.01150.06K
2025-03-18Opaleye Management Inc.Sell5.00K$29.64148.20K
2025-02-28Opaleye Management Inc.Sell5.00K$28.05140.25K
2025-01-22Opaleye Management Inc.Sell20.00K$35.59711.81K
2025-01-06Shojaei AmirBuy30.00K$35.961.08M
2025-01-06Shojaei AmirOther0——
2024-09-11SAHAREK JOHN P.Buy90.00K$7.37663.30K
2024-09-11SAHAREK JOHN P.Sell45.14K$41.371.87M
2024-09-11SAHAREK JOHN P.Sell90.00K$7.37663.30K
2024-06-14Sternberg Perry J.Buy8.35K——
2024-06-14Makary Martin A.Buy8.35K——
2024-06-14Graves Adrienne LBuy8.35K——
2024-06-14SILVERNAIL LAUREN PBuy8.35K——
2024-04-25Opaleye Management Inc.Buy20.00K$9.97199.40K
2024-04-24Opaleye Management Inc.Buy8.29K$10.1584.09K
2024-04-23Opaleye Management Inc.Buy11.71K$10.29120.55K
2024-04-19Opaleye Management Inc.Buy29.40K$10.56310.39K
2024-03-28Opaleye Management Inc.Buy50.00K$12.82641.00K
2024-03-22BAUM MARK LBuy9.00K$11.59104.31K
2024-03-20Opaleye Management Inc.Buy50.60K$9.65488.29K
2024-03-01SAHAREK JOHN P.Buy5.00K$8.7543.75K
2024-03-01SAHAREK JOHN P.Sell5.00K$8.7543.75K
2024-02-20SAHAREK JOHN P.Buy30.00K$10.67320.10K
2024-02-20SAHAREK JOHN P.Sell12.62K$10.67134.61K
2024-02-20SAHAREK JOHN P.Sell30.00K——
2024-02-20BOLL ANDREW R.Buy45.00K$10.67480.15K
2024-02-20BOLL ANDREW R.Sell18.48K$10.67197.18K
2024-02-20BOLL ANDREW R.Sell45.00K——
2024-02-20BAUM MARK LBuy150.00K$10.671.60M
2024-02-20BAUM MARK LSell59.84K$10.67638.45K
2024-02-20BAUM MARK LSell150.00K——
2024-02-07BAUM MARK LBuy15.40K$7.71118.73K
2024-02-07BAUM MARK LSell15.40K$7.71118.73K
2024-02-07BOLL ANDREW R.Buy7.40K$7.7157.05K
2024-02-07BOLL ANDREW R.Sell7.40K$7.7157.05K
2024-01-26Graves Adrienne LBuy3.12K——
2024-01-26SILVERNAIL LAUREN PBuy3.12K——
2024-01-26SILVERNAIL LAUREN POther0——
2024-01-26Graves Adrienne LOther0——
2023-11-16BAUM MARK LBuy7.50K$8.1160.82K
2023-11-15Opaleye Management Inc.Buy25.00K$8.03200.74K
2023-11-10SAHAREK JOHN P.Buy20.00K——
2023-11-10SAHAREK JOHN P.Sell9.78K$12.83125.45K
2023-11-10SAHAREK JOHN P.Sell20.00K$4.1683.20K
2023-09-20Opaleye Management Inc.Buy5.98K$14.4986.71K
2023-09-19Opaleye Management Inc.Buy14.02K$14.65205.37K
2023-08-14BAUM MARK LBuy5.80K$17.0598.89K
2023-08-14Makary Martin A.Buy20.00K$16.92338.40K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 234, holders +7 vs prior quarter. Ownership 58.49%.

HolderSharesChangeChange %Value
BLACKROCK, INC.2.74M187.36K+7.34%116.37M
OPALEYE MANAGEMENT INC.2.40M-432.23K-15.26%101.93M
PRIVATE CAPITAL MANAGEMENT, LLC1.60M1.56M+3799.44%67.90M
VANGUARD CAPITAL MANAGEMENT LLC1.42M14.16K+1.01%60.19M
DEEP TRACK CAPITAL, LP969.00K969.00KNew41.15M
STATE STREET CORP939.89K84.84K+9.92%39.92M
GEODE CAPITAL MANAGEMENT, LLC905.56K53.53K+6.28%38.47M
BAMCO INC /NY/809.35K809.35KNew34.37M
SUSQUEHANNA INTERNATIONAL GROUP, LLP742.90K434.60K+140.97%31.55M
DIMENSIONAL FUND ADVISORS LP667.04K87.52K+15.10%28.33M
JUPITER TOPCO LLC579.13K579.13KNew24.60M
DIVISADERO STREET CAPITAL MANAGEMENT, LP439.15K439.15KNew18.65M
CITADEL ADVISORS LLC391.40K221.30K+130.10%16.62M
RICE HALL JAMES & ASSOCIATES, LLC387.55K19.37K+5.26%16.46M
MARSHALL WACE, LLP369.44K-275.48K-42.72%15.69M
CITADEL ADVISORS LLC359.87K189.77K+111.57%15.28M
NORTHERN TRUST CORP323.21K26.34K+8.87%13.73M
SCHONFELD STRATEGIC ADVISORS LLC319.62K319.62KNew13.57M
VANGUARD PORTFOLIO MANAGEMENT LLC318.61K29.73K+10.29%13.53M
CHARLES SCHWAB INVESTMENT MANAGEMENT INC273.70K3.16K+1.17%11.62M
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P.273.70K273.70KNew11.62M
VANGUARD FIDUCIARY TRUST CO235.42K7.80K+3.43%10.00M
CITADEL ADVISORS LLC233.00K62.90K+36.98%9.90M
WESTSIDE INVESTMENT MANAGEMENT, INC.224.05K38.12K+20.51%9.52M
FIRSTWAVE CAPITAL MANAGEMENT LLC211.98K68.06K+47.29%9.00M

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Harrow Health (HROW) Stock Insights

HROW$29.39+0.32 +1.10%

$1.10B

Market Cap

-28.65

P/E

13.48

Forward P/E

58

Score

Price History